Orser Capital Management, LLC Abb Vie Inc. Transaction History

Orser Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 02, 2021	BUY	$80.49 - $108.67 $14,488 - $19,560	180 Added 2.35%	7,851 $841,000
Q4 2019 Jan 17, 2020	BUY	$72.13 - $90.25 $538,883 - $674,257	7,471 Added 3735.5%	7,671 $679,000
Q3 2019 Oct 31, 2019	BUY	$62.98 - $75.72 $12,596 - $15,144	200 New	200 $15,000
Q2 2018 Nov 14, 2019	SELL	$89.78 - $106.23 $328,684 - $388,908	-3,661 Closed	0 $0
Q1 2018 Nov 14, 2019	BUY	$92.01 - $123.21 $336,848 - $451,071	3,661 New	3,661 $365,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Orser Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Orser Capital Management, LLC with notifications on news.